Alkem Laboratories Ltd
NSE:ALKEM
| US |
|
Johnson & Johnson
NYSE:JNJ
|
Pharmaceuticals
|
| US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
Financial Services
|
| US |
|
Bank of America Corp
NYSE:BAC
|
Banking
|
| US |
|
Mastercard Inc
NYSE:MA
|
Technology
|
| US |
|
Abbvie Inc
NYSE:ABBV
|
Biotechnology
|
| US |
|
Pfizer Inc
NYSE:PFE
|
Pharmaceuticals
|
| US |
|
Palantir Technologies Inc
NYSE:PLTR
|
Technology
|
| US |
|
Nike Inc
NYSE:NKE
|
Textiles, Apparel & Luxury Goods
|
| US |
|
Visa Inc
NYSE:V
|
Technology
|
| CN |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
Retail
|
| US |
|
3M Co
NYSE:MMM
|
Industrial Conglomerates
|
| US |
|
JPMorgan Chase & Co
NYSE:JPM
|
Banking
|
| US |
|
Coca-Cola Co
NYSE:KO
|
Beverages
|
| US |
|
Realty Income Corp
NYSE:O
|
Real Estate
|
| US |
|
Verizon Communications Inc
NYSE:VZ
|
Telecommunication
|
| US |
|
Walt Disney Co
NYSE:DIS
|
Media
|
If you don’t study any companies, you have the same success buying stocks as you do in a poker game if you bet without looking at your cards.
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
This note will be permanently deleted.
Alkem Laboratories Ltd
Alkem Laboratories Ltd
Operating Income
Alkem Laboratories Ltd
Operating Income Peer Comparison
DRREDDY
CIPLA
SUNPHARMA
ZYDUSLIFE
Competitive Operating Income Analysis
Latest Figures & CAGR of Competitors
| Company | Operating Income | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
|---|---|---|---|---|---|
|
|
Alkem Laboratories Ltd
NSE:ALKEM
|
Operating Income
₹19.5B
|
CAGR 3-Years
5%
|
CAGR 5-Years
15%
|
CAGR 10-Years
N/A
|
|
|
Dr Reddy's Laboratories Ltd
NSE:DRREDDY
|
Operating Income
₹64.6B
|
CAGR 3-Years
25%
|
CAGR 5-Years
26%
|
CAGR 10-Years
N/A
|
|
|
Cipla Ltd
NSE:CIPLA
|
Operating Income
₹52.4B
|
CAGR 3-Years
17%
|
CAGR 5-Years
21%
|
CAGR 10-Years
12%
|
|
|
Sun Pharmaceutical Industries Ltd
NSE:SUNPHARMA
|
Operating Income
₹104.3B
|
CAGR 3-Years
17%
|
CAGR 5-Years
16%
|
CAGR 10-Years
5%
|
|
|
Zydus Lifesciences Ltd
NSE:ZYDUSLIFE
|
Operating Income
₹45.4B
|
CAGR 3-Years
18%
|
CAGR 5-Years
14%
|
CAGR 10-Years
16%
|
|
T
|
Torrent Pharmaceuticals Ltd
NSE:TORNTPHARM
|
Operating Income
₹25.6B
|
CAGR 3-Years
12%
|
CAGR 5-Years
13%
|
CAGR 10-Years
11%
|
See Also
What is Alkem Laboratories Ltd's Operating Income?
Operating Income
19.5B
INR
Based on the financial report for Mar 31, 2024, Alkem Laboratories Ltd's Operating Income amounts to 19.5B INR.
What is Alkem Laboratories Ltd's Operating Income growth rate?
Operating Income CAGR 5Y
15%
Over the last year, the Operating Income growth was 41%. The average annual Operating Income growth rates for Alkem Laboratories Ltd have been 5% over the past three years , 15% over the past five years .
You don't have any saved screeners yet
